Wedge Networks Inc. (“Wedge”) today announced that Edgecore Networks, a leading provider of traditional and open network solutions for enterprises, data centers, and telecommunication service providers, has partnered with Wedge Networks to offer a next-generation network security solution to its customers. Wedge Networks’ Wedge Cloud Network Defense (WedgeCND™), is a cloud-managed security service designed to provide comprehensive security protection.
Wedge Networks Inc. (“Wedge”) today announced the signing of a Distributor Agreement with Seaspring W.L.L. (“Seaspring”), a Bahrain-based international investment consultancy firm and a Wedge shareholder. This collaboration aims at delivering innovative cyberthreat prevention solutions to enterprises, small businesses, government departments, service providers, and data centres, while simultaneously expanding the Company’s presence in the region. Together, Wedge and Seaspring will bring the Wedge Absolute Real-Time Protection (“WedgeARP™”) Series, an exclusive real-time threat prevention solutions in the industry, to the active markets of Bahrain and the MENA region.
Asep Medical Holdings Inc. (Asep Inc.) is delighted to announce the recent signing of a Letter of Intent (LOI) for a joint venture between Asep Inc. and Seaspring W.L.L (Seaspring). The joint venture will be owned 50/50 between Asep Inc. and Seaspring pursuant to a definitive agreement. As per the terms of the LOI that was signed by both parties on December 11, 2022 in Bahrain, Seaspring will contribute the capital required by the joint venture to conduct its business operations while Asep Inc. will provide the licensing rights for use of the technology in the Kingdom of Bahrain and the Middle East and North Africa (MENA) region.
Biotricity Inc. (Biotricity) today announced it has surpassed $10 million in annual revenue run rate. “With strong revenue growth each quarter, our scale and market reach increases every day. I am committed to continuing to drive growth and realize our potential,” says Biotricity Founder and CEO, Dr. Waqaas Al-Siddiq.
Biotricity Inc. (Biotricity) has signed a distribution agreement with one of the Top 10 US medical device distributors to distribute its cardiac monitoring solutions, Bioflux and Biotres. With the commercialization of its Bioflux and Biotres products, Biotricity has increased its total addressable market from $1 billion to approximately $6 billion.
Biotricity Inc. (Biotricity) today announced that its Bioheart device has been named to TIME’s list of the Best Inventions of 2022. Bioheart is the first of its kind – a continuous heart rhythm monitor using advanced technology to deliver unlimited heart data insights.
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac. The national roll-out follows two successful pilot programs in Oklahoma City with CardioVascular Health Clinic, a medical facility providing high-quality cardiovascular care to more than 40,000 patients, and a four-month pilot with Lexington Heart Specialists in Kentucky, a medical practice providing high-quality cardiovascular care to more than 20,000 patients.
Biotricity Inc. (Biotricity) today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux®, Biotricity’s high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient’s ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux’s built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence (AI).
Biotricity Inc. (Biotricity), today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease (‘CKD’). The risk of ischemic and hemorrhagic stroke is 5 to 30 times higher in patients with CKD and has a mortality rate of up to three times that of the general population. Effective stroke risk prediction is currently flawed in CKD patients because comorbidities often remain undiagnosed and stroke risk stratification schemes do not consider stages of CKD. Additionally, the detection of stroke-risk variations due to dialysis requires real-time risk monitoring, which is unavailable to date.
Wedge Networks Inc. (Wedge) today announced its partnership with SecureServ, an Australian-based cyber security solutions and network performance distributor. The partnership will afford SecureServ the opportunity to deliver powerful new threat prevention with innovative solutions for Enterprises, Small Businesses, Government Departments, Service Providers and Data Centres, while simultaneously expanding its partner community in the region.
